Archives for December 12, 2005

← 2005

Weekly Comment

The shimmer of patent valuation

Complex webs of assumptions are spinning a lie about the real value of today's companies, lulling directors and shareholders alike into a false sense of value creation.

Atrium swells presence with Douglas acquisition

By  Staff Reporter

Canada's Atrium Biotechnologies says it has landed in the top spot in the US market for health and nutritional supplements marketed to health care practitioners, thanks to its C$107 million (US$92 million) acquisition of HVL, best known for its...